Benjamin P Linas

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc Assessing the impact of federal HIV prevention spending on HIV testing and awareness
    Benjamin P Linas
    Massachusetts General Hospital, 50 Staniford St, Ninth Floor, Boston, MA 02114, USA
    Am J Public Health 96:1038-43. 2006
  2. ncbi request reprint Optimizing resource allocation in United States AIDS drug assistance programs
    Benjamin P Linas
    Division of General Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Clin Infect Dis 43:1357-64. 2006
  3. pmc Improving outcomes in state AIDS drug assistance programs
    Benjamin P Linas
    Divisions of General Medicine, Massachusetts General Hospital, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 51:513-21. 2009
  4. pmc The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort
    B P Linas
    Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
    J Viral Hepat 18:506-12. 2011
  5. pmc Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC
    Rochelle P Walensky
    Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Clin Infect Dis 51:392-400. 2010
  6. pmc When to start antiretroviral therapy in resource-limited settings
    Rochelle P Walensky
    Massachusetts General Hospital, Brigham and Women s Hospital, Harvard University Medical School, Harvard School of Public Health, and Boston University School of Public Health, Boston, Massachusetts 02114, USA
    Ann Intern Med 151:157-66. 2009
  7. doi request reprint The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients
    Benjamin P Linas
    aSection of Infectious Diseases, Department of Medicine, Boston Medical Center bDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts cDepartment of Public Health, Weill Cornell Medical College, New York, New York dDivision of General Medicine, Massachusetts General Hospital eDivision of Infectious Diseases, Massachusetts General Hospital fDepartment of Global Health and Population gDepartment of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS 28:365-76. 2014
  8. pmc Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men
    Benjamin P Linas
    HIV Epidemiology and Outcomes Research Unit, Section of Infectious Diseases, Boston Medical Center, Boston, MA 02118, USA
    Clin Infect Dis 55:279-90. 2012
  9. pmc WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers
    Andrea L Ciaranello
    Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 6:e20224. 2011
  10. pmc Cost-effectiveness of surveillance strategies after treatment for high-grade anal dysplasia in high-risk patients
    Sabrina A Assoumou
    Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, USA
    Sex Transm Dis 40:298-303. 2013

Research Grants

Detail Information

Publications11

  1. pmc Assessing the impact of federal HIV prevention spending on HIV testing and awareness
    Benjamin P Linas
    Massachusetts General Hospital, 50 Staniford St, Ninth Floor, Boston, MA 02114, USA
    Am J Public Health 96:1038-43. 2006
    ..The United States allocates more than $900 million annually for the prevention of HIV infection. We assessed the impact of this funding on HIV testing and knowledge...
  2. ncbi request reprint Optimizing resource allocation in United States AIDS drug assistance programs
    Benjamin P Linas
    Division of General Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Clin Infect Dis 43:1357-64. 2006
    ..We hypothesized that CD4 cell count-based ADAP eligibility would improve ADAP outcomes, allowing them to serve more-diverse patient populations and to prioritize persons who are at greatest risk of HIV-related mortality...
  3. pmc Improving outcomes in state AIDS drug assistance programs
    Benjamin P Linas
    Divisions of General Medicine, Massachusetts General Hospital, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 51:513-21. 2009
    ..State AIDS Drug Assistance Programs (ADAPs) provide antiretroviral medications to patients with no access to medications. Resource constraints limit the ability of many ADAPs to meet demand for services...
  4. pmc The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort
    B P Linas
    Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
    J Viral Hepat 18:506-12. 2011
    ..5), 1.7 (95% CI: 1.4-2.1), and 1.6 (95% CI: 1.3-1.9) respectively. Programs serving HIV/HCV co-infected patients can expect approximately 70% higher rates of utilization than expected from a similar cohort of HIV mono-infected patients...
  5. pmc Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC
    Rochelle P Walensky
    Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Clin Infect Dis 51:392-400. 2010
    ..We forecast outcomes of this approach if implemented in Washington DC...
  6. pmc When to start antiretroviral therapy in resource-limited settings
    Rochelle P Walensky
    Massachusetts General Hospital, Brigham and Women s Hospital, Harvard University Medical School, Harvard School of Public Health, and Boston University School of Public Health, Boston, Massachusetts 02114, USA
    Ann Intern Med 151:157-66. 2009
    ..The results of international clinical trials that are assessing when to initiate antiretroviral therapy (ART) will not be available for several years...
  7. doi request reprint The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients
    Benjamin P Linas
    aSection of Infectious Diseases, Department of Medicine, Boston Medical Center bDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts cDepartment of Public Health, Weill Cornell Medical College, New York, New York dDivision of General Medicine, Massachusetts General Hospital eDivision of Infectious Diseases, Massachusetts General Hospital fDepartment of Global Health and Population gDepartment of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS 28:365-76. 2014
    ..To evaluate the effectiveness and cost-effectiveness of strategies to treat hepatitis C virus (HCV) in HIV/HCV coinfected patients in the United States...
  8. pmc Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men
    Benjamin P Linas
    HIV Epidemiology and Outcomes Research Unit, Section of Infectious Diseases, Boston Medical Center, Boston, MA 02118, USA
    Clin Infect Dis 55:279-90. 2012
    ..We used a Monte Carlo computer simulation to estimate the effectiveness and cost-effectiveness of screening for acute hepatitis C virus (HCV) infection in human immunodeficiency virus (HIV)-infected men who have sex with men...
  9. pmc WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers
    Andrea L Ciaranello
    Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 6:e20224. 2011
    ..The Zimbabwean national prevention of mother-to-child HIV transmission (PMTCT) program provided primarily single-dose nevirapine (sdNVP) from 2002-2009 and is currently replacing sdNVP with more effective antiretroviral (ARV) regimens...
  10. pmc Cost-effectiveness of surveillance strategies after treatment for high-grade anal dysplasia in high-risk patients
    Sabrina A Assoumou
    Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, USA
    Sex Transm Dis 40:298-303. 2013
    ..Currently, there is no consensus on posttreatment surveillance of HIV-infected men who have sex with men (MSM) who have been treated for high-grade intraepithelial neoplasia (HGAIN), the likely precursor to anal cancer...
  11. pmc First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial
    Andrea L Ciaranello
    Division of Infectious Disease, Massachusetts General Hospital, Boston, 02114, USA
    AIDS 25:479-92. 2011
    ..nevirapine-based antiretroviral therapy (ART) among women previously exposed to single-dose nevirapine to prevent mother-to-child HIV transmission. However, lopinavir/ritonavir is 12 times costlier than nevirapine...

Research Grants2

  1. Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs
    BENJAMIN LINAS; Fiscal Year: 2007
    ..This K01 award will lead to a novel, independent trajectory of research, and will inform HIV and HCV care and policy in the United States. ..